Navigation Links
8 M € from EU to enhance access by scientists to the largest European 'biobanks'
Date:4/10/2013

In response to a specific infrastructure call of the Seventh Framework Programme (FP7) of the European Commission, BBMRI-LPC*, a European-wide project involving 30 partners from 17 countries, has received a 8M funding to enhance access by academic and industry scientists to the largest European 'biobanks'.

The project represents the next phase of the successful EU biobanking programme BBMRI (Biobanking and Biomolecular Resources Research Infrastructure), which was operational from 2007-2011.

BBMRI-LPC led by the University Medical Centers of Helsinki (Finland) and Leiden (the Netherlands) had its kick-off meeting in Amsterdam 11-12 February and will now run for the following 4 years. The project will specifically focus on large population cohorts and aims to enable academic and industrial scientists to improve our understanding of human biology, thereby leading to novel and better medicines and treatments for common and rare diseases.

Over recent years, biomedical research has crossed international borders in large, collaborative studies substantiating the value of collaboration between experts from different fields as well as the value of large numbers of samples. In the past decades, European countries have invested millions euros of funding and substantial amount of time for the establishment of large collections of volunteering individuals' biological samples and health-related information to be used in the research of human health and disease. The access to this study material, however, is often hindered by the limited resources for sharing samples and data between the fellow scientists, and by differences between nearby countries in their legal and ethical procedures.

The BBMRI-LPC project endeavors to unite the large study sets of the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) and the International Agency for Research on Cancer (IARC), thereby achieving a biobanking network with a scale of integration that is unique worldwide. BBMRI-LPC will assist the European health industry by promoting new and existing public-private partnerships, which will strengthen the European niche in the development of medicine and treatments as well as assist governments in returning the investment made by all European tax payers.


'/>"/>

Contact: Markus Perola
markus.perola@helsinki.fi
358-206-108-727
University of Helsinki
Source:Eurekalert

Related biology news :

1. New grants to innovation corps nodes further enhance public-private partnership
2. New therapy for heart failure may enhance bodys stem cell response at cardiovascular injury site
3. Hydrogen peroxide vapor enhances hospital disinfection of superbugs
4. Discovery may pave way to genetically enhanced biofuel crops
5. Surface analysis techniques for advanced materials enhance Mazovias research potential
6. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
7. Partnership enhances biology teaching at California community colleges
8. Potential drug molecule shows enhanced anti-HIV activity
9. Ken Bierly of the Oregon Watershed Enhancement Board to receive ESA Regional Policy Award
10. Enhanced royal jelly produces jumbo queen bee larvae
11. Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology: